通过皮肤注射的布隆南塞林补丁对晚期癌症患者接受息护理的过敏 Delirium 的有效性
Yohei Oguri1, Kenji Umeki1, Eiji Ohno2
1Department of Palliative Care, Tenshindo Hetsugi Hospital, Oita, Japan.
Journal of palliative medicine
|March 2, 2026
概括
通过皮肤注射的布隆纳塞林贴片有效地控制了无法服用口服药物的晚期癌症患者的过度活动妄想症. 治疗表现出良好的耐受性,显著改善症状和最小的不良事件.
科学领域:
- 抚慰性护理是一种缓解性护理.
- 在瘤学瘤学.
- 精神病学是一个精神病学.
背景情况:
- 过度活动性妄想在晚期癌症患者中很普遍,导致严重的痛苦.
- 有限的口服药理选择存在于缓解护理环境中管理这种情况.
研究的目的:
- 评估通过皮肤发射的布隆纳塞林贴片在晚期癌症患者中治疗过度活动性妄想的疗效和安全性.
- 评估该贴片作为患有吞困难或无法耐受口服药物的患者的替代品.
主要方法:
- 一项回顾性观察性研究分析了18名晚期癌症患者,这些患者接受了40毫克的透皮布隆纳塞林贴片.
- 主要终点是7天里奇蒙德兴奋-镇静量表-息版本 (RASS-PAL) 评分的变化.
- 监测了安全事件和需要额外的抗精神病药物的情况.
主要成果:
- 通过皮肤注射的布隆纳塞林显著降低了RASS-PAL得分 (中位数从2.0到0.5,p=0.0019).
- 治疗耐受性很好,有一例可逆镇静,没有严重的不良事件,如额外金字塔症状或NMS.
- 五名患者需要救援抗精神病药物,但没有发现初始妄想严重程度的复发.
结论:
- 透皮布隆纳塞林贴片是一种有前途,有效和安全的选择,用于管理口服管理挑战的晚期癌症患者的过度活动妄想症.
- 建议进行进一步的前性研究,以验证这些发现并建立最佳使用协议.
相关概念视频
Transdermal Drug Delivery Systems
64
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
64
Drug Therapy
331
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
331
Psychosis: Goals of Pharmacotherapy
643
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
643
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Drug Delivery: Miscellaneous Routes
891
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
891
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
765
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
765

